Richard Orlowski

Hematology | Oncology
2406 Century Pl Se
Hickory, NC 28602

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.

Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 03, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026